Arbutus Biopharma Corporation ABUS Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's investment purchases?
- Arbutus Biopharma Corporation (ABUS) reported investment purchases of $13.8M in Q1 2026.
- How has Arbutus Biopharma Corporation's investment purchases changed year-over-year?
- Arbutus Biopharma Corporation's investment purchases decreased by 60.2% year-over-year, from $34.72M to $13.8M.
- What is the long-term trend for Arbutus Biopharma Corporation's investment purchases?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's investment purchases has grown at a 14.2% compound annual growth rate (CAGR), from $82.22M to $140.06M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.